Anti-Kir3.3 Antibody (BSA and Azide free)
ABI-75-445-CF 100 µL
Synonyms: Inward rectifier K(+) channel Kir3.3 (Potassium channel, inwardlyrectifying subfamily J member 9) (G protein-activated inward rectifier potassium channel 3) (Kcnj9) (Girk3)
Data Sheet: 
Reactivity
Human, Mouse, and Rat
Applications
WB, IHC, ICC, ELISA
Clone
N455/15
Concentration
1 mg/mL
Shipment
Shipped on ice packs
Long Term Storage
Aliquot and store at ≤ -20°C for long term storage. For short term storage, store at 2-8°C. For maximum recovery of product, centrifuge the vial prior to removing the cap.
Shelf Life
12 months from date of receipt
Description
Our carrier-free Anti-Kir3.3 mouse monoclonal primary antibody from NeuroMab is produced in-house from hybridoma clone N455/15. It is KO validated, detects human, mouse, and rat Kir3.3, and is purified by Protein A chromatography. It is great for use in IHC, ICC, WB. - Potassium inwardly rectifying channel subfamily J member 9 is encoded by the gene KCNJ9. KCNJ9 is a member of the inward rectifier-type potassium channel (TC 1.A.2.1) family, KCNJ9 subfamily. KCNJ9 is an integral membrane protein and inward-rectifier type potassium channel, which has a greater tendency to allow potassium to flow into the cell rather than out of the cell. KCNJ9 is controlled by G-proteins and associates with another G-protein-activated potassium channel to form a heteromultimeric pore-forming complex. KCNJ9 is expressed in the brain and skeletal muscle. Diseases associated with KCNJ9 include Pendred Syndrom and Seizures, Sensorineural Deafness, Ataxia, Mental Retardation, and Electrolyte Imbalance. -
ESCLUSIVAMENTE PER USO DI RICERCA (RUO) e non per uso terapeutico o diagnostico su uomini o animali. Il prodotto NON è un Dispositivo Medico o un Diagnostico in Vitro.
PRODUCT FOR RESEARCH USE ONLY (RUO) and not for therapeutic or diagnostic use on humans or animals. The product is NOT a Medical Device or an In-Vitro Diagnostic (IVD).
